DPTX3186 in Wnt Pathway Activated Solid Tumors

NCT07312903 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Dewpoint Therapeutics